Published in Neuropsychopharmacology on April 13, 2011
Inhalation of 7.5% carbon dioxide increases alerting and orienting attention network function. Psychopharmacology (Berl) (2012) 0.94
Biological markers for anxiety disorders, OCD and PTSD: A consensus statement. Part II: Neurochemistry, neurophysiology and neurocognition. World J Biol Psychiatry (2016) 0.92
Dynamic Dazzle Distorts Speed Perception. PLoS One (2016) 0.86
A Good Death? Report of the Second Newcastle Meeting on Laboratory Animal Euthanasia. Animals (Basel) (2016) 0.82
Effects of 7.5% carbon dioxide inhalation on anxiety and mood in cigarette smokers. J Psychopharmacol (2014) 0.80
Effects of 7.5% carbon dioxide (CO2) inhalation and ethnicity on face memory. Physiol Behav (2015) 0.79
Defensive eye-blink startle responses in a human experimental model of anxiety. J Psychopharmacol (2014) 0.79
Evaluating psychological interventions in a novel experimental human model of anxiety. J Psychiatr Res (2015) 0.77
Early effects of duloxetine on emotion recognition in healthy volunteers. J Psychopharmacol (2015) 0.77
Acute anxiety and social inference: An experimental manipulation with 7.5% carbon dioxide inhalation. J Psychopharmacol (2016) 0.75
Anxiety sensitivity and trait anxiety are associated with response to 7.5% carbon dioxide challenge. J Psychopharmacol (2015) 0.75
State anxiety and emotional face recognition in healthy volunteers. R Soc Open Sci (2017) 0.75
The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry (1998) 65.11
Development and validation of brief measures of positive and negative affect: the PANAS scales. J Pers Soc Psychol (1988) 60.71
The 'Trier Social Stress Test'--a tool for investigating psychobiological stress responses in a laboratory setting. Neuropsychobiology (1993) 11.24
The amygdala: vigilance and emotion. Mol Psychiatry (2001) 10.81
Threat-related attentional bias in anxious and nonanxious individuals: a meta-analytic study. Psychol Bull (2007) 9.11
Anxiety and cognitive performance: attentional control theory. Emotion (2007) 6.26
An insular view of anxiety. Biol Psychiatry (2006) 5.28
Prefrontal cortical function and anxiety: controlling attention to threat-related stimuli. Nat Neurosci (2004) 3.86
Increased amygdala and insula activation during emotion processing in anxiety-prone subjects. Am J Psychiatry (2007) 3.73
Anxiety and affective style: role of prefrontal cortex and amygdala. Biol Psychiatry (2002) 3.68
Neurocognitive mechanisms of anxiety: an integrative account. Trends Cogn Sci (2007) 3.37
Amygdala and ventrolateral prefrontal cortex activation to masked angry faces in children and adolescents with generalized anxiety disorder. Arch Gen Psychiatry (2008) 3.22
The amygdala is a chemosensor that detects carbon dioxide and acidosis to elicit fear behavior. Cell (2009) 3.03
State anxiety modulation of the amygdala response to unattended threat-related stimuli. J Neurosci (2004) 2.86
Does the brain noradrenaline network mediate the effects of the CO2 challenge? J Psychopharmacol (2003) 2.81
Anticipatory activation in the amygdala and anterior cingulate in generalized anxiety disorder and prediction of treatment response. Am J Psychiatry (2009) 2.57
The structural integrity of an amygdala-prefrontal pathway predicts trait anxiety. J Neurosci (2009) 2.35
Biases in eye movements to threatening facial expressions in generalized anxiety disorder and depressive disorder. J Abnorm Psychol (2000) 2.25
Lateral prefrontal cortex mediates the cognitive modification of attentional bias. Biol Psychiatry (2009) 1.70
Carbon dioxide regulates the tonic activity of locus coeruleus neurons by modulating a proton- and polyamine-sensitive inward rectifier potassium current. Neuroscience (1997) 1.63
An expanded anxiety sensitivity index: evidence for a hierarchic structure in a clinical sample. J Anxiety Disord (1999) 1.45
Decomposing the neural correlates of antisaccade eye movements using event-related FMRI. Cereb Cortex (2007) 1.22
Restriction of working memory capacity during worry. J Abnorm Psychol (2008) 1.14
Behavioral and cardiovascular effects of 7.5% CO2 in human volunteers. Depress Anxiety (2005) 1.09
Effects of anxiety on task switching: evidence from the mixed antisaccade task. Cogn Affect Behav Neurosci (2008) 1.03
Noradrenergic modulation of cortical networks engaged in visuomotor processing. Cereb Cortex (2009) 1.02
Carbon dioxide-induced emotion and respiratory symptoms in healthy volunteers. Neuropsychopharmacology (2008) 0.95
Panic symptoms after inhalation of carbon dioxide. Br J Psychiatry (1984) 0.93
A validation of the 7.5% CO2 model of GAD using paroxetine and lorazepam in healthy volunteers. J Psychopharmacol (2006) 0.93
Characterization of a 7% carbon dioxide (CO2) inhalation paradigm to evoke anxiety symptoms in healthy subjects. J Psychopharmacol (2005) 0.84
GABA-A receptors and the response to CO(2) inhalation - a translational trans-species model of anxiety? Pharmacol Biochem Behav (2008) 0.79
Power failure: why small sample size undermines the reliability of neuroscience. Nat Rev Neurosci (2013) 13.37
Interventions for smoking cessation in hospitalised patients. Cochrane Database Syst Rev (2012) 3.78
Delayed reward discounting and addictive behavior: a meta-analysis. Psychopharmacology (Berl) (2011) 3.57
Meta-analysis of the cognitive effects of the catechol-O-methyltransferase gene Val158/108Met polymorphism. Biol Psychiatry (2008) 3.09
Weekly versus basic smoking cessation support in primary care: a randomised controlled trial. Thorax (2007) 2.86
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and post-traumatic stress disorders - first revision. World J Biol Psychiatry (2008) 2.64
Antidepressant medications and other treatments of depressive disorders: a CINP Task Force report based on a review of evidence. Int J Neuropsychopharmacol (2007) 2.60
The endophenotype concept in psychiatric genetics. Psychol Med (2006) 2.49
Structural neuroimaging studies in major depressive disorder. Meta-analysis and comparison with bipolar disorder. Arch Gen Psychiatry (2011) 2.47
Internal reliability of measures of substance-related cognitive bias. Drug Alcohol Depend (2011) 2.47
Ventral striatum/nucleus accumbens activation to smoking-related pictorial cues in smokers and nonsmokers: a functional magnetic resonance imaging study. Biol Psychiatry (2005) 2.17
A meta-analytic investigation of the relationship between attentional bias and subjective craving in substance abuse. Psychol Bull (2009) 2.08
Forum: Interactions between gene and environment. Curr Opin Psychiatry (2008) 1.86
Which factors predict placebo response in anxiety disorders and major depression? An analysis of placebo-controlled studies of escitalopram. J Clin Psychiatry (2006) 1.78
Association of COMT Val108/158Met genotype with smoking cessation in a nicotine replacement therapy randomized trial. Cancer Epidemiol Biomarkers Prev (2007) 1.62
The serotonin transporter length polymorphism, neuroticism, and depression: a comprehensive assessment of association. Biol Psychiatry (2005) 1.55
Using genetic data in cognitive neuroscience: from growing pains to genuine insights. Nat Rev Neurosci (2008) 1.53
Association of the CHRNA5-A3-B4 gene cluster with heaviness of smoking: a meta-analysis. Nicotine Tob Res (2011) 1.51
Visual attention to health warnings on plain tobacco packaging in adolescent smokers and non-smokers. Addiction (2012) 1.49
What is the threshold for symptomatic response and remission for major depressive disorder, panic disorder, social anxiety disorder, and generalized anxiety disorder? J Clin Psychiatry (2006) 1.48
Antidepressants and their effect on sleep. Hum Psychopharmacol (2005) 1.48
Stability of autistic traits in the general population: further evidence for a continuum of impairment. J Am Acad Child Adolesc Psychiatry (2011) 1.44
Genetics and smoking cessation improving outcomes in smokers at risk. Am J Prev Med (2007) 1.33
From men to mice: CHRNA5/CHRNA3, smoking behavior and disease. Nicotine Tob Res (2012) 1.31
Reducing harm from tobacco use. J Psychopharmacol (2012) 1.26
Pharmacogenetic clinical trial of sustained-release bupropion for smoking cessation. Nicotine Tob Res (2007) 1.26
Bupropion efficacy for smoking cessation is influenced by the DRD2 Taq1A polymorphism: analysis of pooled data from two clinical trials. Nicotine Tob Res (2007) 1.21
Effects of Acute Nicotine Abstinence on Cue-elicited Ventral Striatum/Nucleus Accumbens Activation in Female Cigarette Smokers: A Functional Magnetic Resonance Imaging Study. Brain Imaging Behav (2007) 1.17
Candidate and non-candidate genes in behavior genetics. Curr Opin Neurobiol (2012) 1.17
Pathways between childhood victimization and psychosis-like symptoms in the ALSPAC birth cohort. Schizophr Bull (2012) 1.11
Genome-wide association for smoking cessation success: participants in the Patch in Practice trial of nicotine replacement. Pharmacogenomics (2010) 1.10
Effects of acute tyrosine/phenylalanine depletion on the selective processing of smoking-related cues and the relative value of cigarettes in smokers. Psychopharmacology (Berl) (2007) 1.10
Attentional bias training and cue reactivity in cigarette smokers. Addiction (2008) 1.08
Effects of caffeine on alcohol-related changes in behavioural control and perceived intoxication in light caffeine consumers. Psychopharmacology (Berl) (2011) 1.08
Which antidepressants have demonstrated superior efficacy? A review of the evidence. Int Clin Psychopharmacol (2007) 1.07
Bias in genetic association studies: effects of research location and resources. Psychol Med (2008) 1.07
Cigarette smoking and depression: a question of causation. Br J Psychiatry (2010) 1.07
Characterizing patterns of smoking initiation in adolescence: comparison of methods for dealing with missing data. Nicotine Tob Res (2011) 1.06
Potential reporting bias in fMRI studies of the brain. PLoS One (2013) 1.05
Increasing recognition of happiness in ambiguous facial expressions reduces anger and aggressive behavior. Psychol Sci (2013) 1.04
Patterns of alcohol use in early adolescence predict problem use at age 16. Alcohol Alcohol (2012) 1.02
Longitudinal analysis of the effect of prenatal nicotine exposure on subsequent smoking behavior of offspring. Nicotine Tob Res (2005) 1.01
On the persistence of low power in psychological science. Q J Exp Psychol (Hove) (2014) 1.01
Electrophysiological indices of biased cognitive processing of substance-related cues: a meta-analysis. Neurosci Biobehav Rev (2012) 1.00
Amphetamine as a social drug: effects of d-amphetamine on social processing and behavior. Psychopharmacology (Berl) (2012) 0.99
Will peak provoked craving prove superior to cue-reactivity? Addiction (2013) 0.99
Effects of emotion perception training on mood in undergraduate students: randomised controlled trial. Br J Psychiatry (2012) 0.99
Glass shape influences consumption rate for alcoholic beverages. PLoS One (2012) 0.98
How reliable are scientific studies? Br J Psychiatry (2010) 0.98
Lack of association between COMT and working memory in a population-based cohort of healthy young adults. Neuropsychopharmacology (2013) 0.98
Reliability and replicability of genetic association studies. Addiction (2009) 0.97
Outcomes of childhood conduct problem trajectories in early adulthood: findings from the ALSPAC study. Eur Child Adolesc Psychiatry (2013) 0.96
Confidence and precision increase with high statistical power. Nat Rev Neurosci (2013) 0.95
No psychiatry without psychopharmacology. Br J Psychiatry (2011) 0.95
Maternal smoking during pregnancy and offspring smoking initiation: assessing the role of intrauterine exposure. Addiction (2014) 0.94
Inhalation of 7.5% carbon dioxide increases alerting and orienting attention network function. Psychopharmacology (Berl) (2012) 0.94
Testing times. Addiction (2012) 0.94
Adolescent cannabis and tobacco use and educational outcomes at age 16: birth cohort study. Addiction (2015) 0.93
A translational rodent assay of affective biases in depression and antidepressant therapy. Neuropsychopharmacology (2013) 0.92
The generalized anxiety spectrum: prevalence, onset, course and outcome. Eur Arch Psychiatry Clin Neurosci (2008) 0.92
Investigating the psychopharmacology of cognitive affective bias in rats using an affective tone discrimination task. Psychopharmacology (Berl) (2012) 0.92
Effects of alcohol consumption and alcohol expectancy on the categorisation of perceptual cues of emotional expression. Psychopharmacology (Berl) (2009) 0.92
The serotonin transporter 5-HTTLPR polymorphism and treatment response to nicotine patch: follow-up of a randomized controlled trial. Nicotine Tob Res (2007) 0.92
Effect on adherence to nicotine replacement therapy of informing smokers their dose is determined by their genotype: a randomised controlled trial. PLoS One (2012) 0.91
Psychosocial working conditions and work-related stressors among UK veterinary surgeons. Occup Med (Lond) (2009) 0.90
A neuroimmunological perspective on anxiety disorders. Hum Psychopharmacol (2011) 0.90
Superiority of escitalopram to paroxetine in the treatment of depression. Eur Neuropsychopharmacol (2009) 0.90
Research in anxiety disorders: from the bench to the bedside. Eur Neuropsychopharmacol (2009) 0.89
Acute anxiety impairs accuracy in identifying photographed faces. Psychol Sci (2013) 0.89
Effects of acute nicotine and alcohol on the rating of attractiveness in social smokers and alcohol drinkers. Drug Alcohol Depend (2012) 0.89
Efficacy of pregabalin in depressive symptoms associated with generalized anxiety disorder: a pooled analysis of 6 studies. Eur Neuropsychopharmacol (2008) 0.89
A family smoking index to capture genetic influence in smoking: rationale and two validation studies. Nicotine Tob Res (2005) 0.89
Serotonin norepinephrine reuptake inhibitors (SNRIs) in anxiety disorders: a comprehensive review of their clinical efficacy. Hum Psychopharmacol (2010) 0.89
Can long-term outcomes be improved by shortening the duration of untreated illness in psychiatric disorders? A conceptual framework. Psychopathology (2012) 0.89
What's the matter with cue-induced craving? A commentary on Perkins. Addiction (2010) 0.89
Effects of alcohol on disinhibition towards alcohol-related cues. Drug Alcohol Depend (2012) 0.88
Trial Protocol: Using genotype to tailor prescribing of nicotine replacement therapy: a randomised controlled trial assessing impact of communication upon adherence. BMC Public Health (2010) 0.88
Pharmacogenetics of smoking cessation in general practice: results from the patch II and patch in practice trials. Nicotine Tob Res (2011) 0.88
Effects of acute nicotine administration on ratings of attractiveness of facial cues. Nicotine Tob Res (2009) 0.88
Using Mendelian randomisation to infer causality in depression and anxiety research. Depress Anxiety (2013) 0.88
Evaluation of a novel translational task for assessing emotional biases in different species. Cogn Affect Behav Neurosci (2012) 0.88
Genetic variation in the dopamine pathway and smoking cessation. Pharmacogenomics (2008) 0.88
Executive summary of the report by the WPA section on pharmacopsychiatry on general and comparative efficacy and effectiveness of antidepressants in the acute treatment of depressive disorders. Eur Arch Psychiatry Clin Neurosci (2011) 0.88
Plain cigarette packs do not exert Pavlovian to instrumental transfer of control over tobacco-seeking. Addiction (2014) 0.88
Effects of venlafaxine extended release on resilience in posttraumatic stress disorder: an item analysis of the Connor-Davidson Resilience Scale. Int Clin Psychopharmacol (2008) 0.87
Significance chasing in research practice: causes, consequences and possible solutions. Addiction (2014) 0.87
The effect of focused attention and open monitoring meditation on attention network function in healthy volunteers. Psychiatry Res (2013) 0.87
Do SSRIs or antidepressants in general increase suicidality? WPA Section on Pharmacopsychiatry: consensus statement. Eur Arch Psychiatry Clin Neurosci (2008) 0.87
Acute alcohol impairs human goal-directed action. Biol Psychol (2012) 0.87
Effects of acute alcohol consumption and alcohol expectancy on processing of perceptual cues of emotional expression. J Psychopharmacol (2008) 0.86
Quantifying subjective assessment of sleep and life-quality in antidepressant-treated depressed patients. Hum Psychopharmacol (2003) 0.86
A recall-by-genotype study of CHRNA5-A3-B4 genotype, cotinine and smoking topography: study protocol. BMC Med Genet (2014) 0.86
Acutely induced anxiety increases negative interpretations of events in a closed-circuit television monitoring task. Cogn Emot (2012) 0.86
Effect of short-term SSRI treatment on cognitive bias in generalised anxiety disorder. Psychopharmacology (Berl) (2004) 0.86
Estimating the prevalence and impact of antidepressant-induced sexual dysfunction in 2 European countries: a cross-sectional patient survey. J Clin Psychiatry (2006) 0.85
Effect of social stress during acute nicotine abstinence. Psychopharmacology (Berl) (2011) 0.85
Genetic variation in the serotonin pathway and smoking cessation with nicotine replacement therapy: new data from the Patch in Practice trial and pooled analyses. Drug Alcohol Depend (2008) 0.85
Effects of acute alcohol consumption on alcohol-related cognitive biases in light and heavy drinkers are task-dependent. J Psychopharmacol (2011) 0.85